Long-Term Efficacy, Safety, and Drug Survival of Guselkumab in Patients with Psoriasis: Real-World Data from the Czech Republic BIOREP Registry

• Główni autorzy: Jan Hugo (Autor), Martina Kojanova (Autor), Barbora Turkova (Autor), Spyridon Gkalpakiotis (Autor), the BIOREP Study Group (Autor)
• Format: Książka
• Wydane: Adis, Springer Healthcare, 2023-02-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Abstract Background Real-world data on the long-term use of guselkumab for treatment of psoriasis are still limited. Objective We aimed to evaluate long-term efficacy, safety, and drug survival of guselkumab in a real-world setting. Methods This is a retrospective study analyzing Czech Republic regi...